RNAM - Avidity Biosciences Inc
0 0%
Share volume: 0
Last Updated:
Pharmaceutical Products/Pharmaceutical Preparations:
3.19%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 12-31-2025 | |
|---|---|---|
| Fiscal Quarter | Q4 2025 | |
| Report Date | 02-23-2026 | |
| Cash flow financing | -5.086 M | |
| Other financing cash flows | 0.000 | |
| Cash flow | 32.359 M | |
| Net income | -237.101 M | |
| Depreciation | 1.496 M | |
| Changes in inventories | 0.000 | |
| Changes in receivables | 0.000 | |
| Investing Cashflow | 207.218 M | |
| Net Borrowings | 0.000 | |
| Investing Activity Other | -891.000 K | |
| Dividends Paid | 0.000 | |
| Exchange Rate Effect | 0.000 | |
| Capital Expenditures | 5.511 M | |
| Cash Change | 32.358 M |